Golgi Signature Predicts Gastric Cancer Immunity, Prognosis

Golgi Signature Predicts Gastric Cancer Immunity, Prognosis

In a groundbreaking advance that deepens our understanding of gastric cancer biology, researchers have unveiled a novel prognostic signature intimately tied to the Golgi apparatus, a pivotal organelle often overshadowed in cancer research. This new Golgi apparatus-related risk score (GARS) emerges not only as a powerful predictor of gastric cancer outcomes but also as a compass guiding therapeutic decisions, from chemotherapy regimens to immunot…

When science connects with real needs, solutions like this emerge: a Chilean probiotic, developed in Concepción, could help prevent gastric cancer. From his laboratory in Concepción, García promotes accessible solutions to prevent gastric diseases. Helicobacter pylori is a bacterium that settles in the stomach lining and is estimated to affect between 60% and 80% of the adult population in Chile. In most cases, its presence is asymptomatic and c…